18.36
Finanzdaten der Biolife Solutions Inc-Aktie (BLFS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
33.07%
18.79
|
28.07 | 25.42 | 23.94 | 30.57 |
|
|
159.16%
-16.66
|
28.16 | 42.06 | 25.16 | 32.13 |
| Benefits Costs and Expenses |
43.64%
15.42
|
27.36 | 41.13 | 24.38 | 32.30 |
| Costs And Expenses |
159.16%
-16.66
|
28.16 | 42.06 | 25.16 | 32.13 |
| Operating Income/Loss |
1,613%
1.347
|
-0.089 | -16.64 | -1.218 | -1.559 |
| Nonoperating Income/Loss |
154.42%
2.015
|
0.792 | 0.931 | 0.784 | -0.172 |
| Income/Loss From Continuing Operations Before Tax |
378.24%
3.362
|
0.703 | -15.71 | -0.434 | -1.731 |
| Income Tax Expense/Benefit, Deferred |
100.00%
-
|
0.014 | 0.045 | 0.006 | -0.093 |
| Income Tax Expense/Benefit |
310.98%
-0.173
|
0.082 | 0.126 | 0.014 | -0.028 |
| Income/Loss From Continuing Operations After Tax |
469.24%
3.535
|
0.621 | -15.84 | -0.448 | -1.703 |
| Income/Loss From Discontinued Operations, Net Of Tax |
7.535
|
- | - | - | - |
|
|
1,683%
11.07
|
0.621 | -15.84 | -0.448 | -1.703 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.73%
0.1316
|
47.93 | 47.80 | 47.13 | 46.18 |
| Diluted Average Shares |
97.90%
1.0229
|
48.72 | 47.80 | 47.13 | 46.18 |
| Basic Earnings Per Share |
2,300%
0.24
|
0.01 | -0.33 | -0.01 | -0.04 |
| Diluted Earnings Per Share |
2,200%
0.23
|
0.01 | -0.33 | -0.01 | -0.04 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):